Physician profile
Kimberly D Larson
NPI 1972545978
$845.12
in general payments reported to CMS, 2019-2025
12 companies · $98.26 in 2025
The $98.26 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.70 · 2022: $192 · 2023: $383 · 2024: $77.54 · 2025: $98.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.19 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $254.99 | 2023-2024 | Veozah |
| Novo Nordisk INC | $125.00 | 2023 | Wegovy |
| Abbvie INC. | $123.20 | 2021-2022 | |
| Exact Sciences Corporation | $78.30 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $61.79 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $45.91 | 2025 | Myfembree |
| Myovant Sciences INC. | $38.59 | 2021-2022 | |
| Coopersurgical, INC. | $36.05 | 2021-2022 | |
| Hologic Sales and Service, LLC | $34.25 | 2021-2025 | Aptima |
| Glaxosmithkline, LLC. | $20.74 | 2022 | |
| Merck Sharp & Dohme LLC | $14.05 | 2024 | Gardasil 9, Gardasil |
| Agile Therapeutics, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.